# Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

> **NCT00391209** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 379 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** simplified diabetes regimen starting with a fixed dose of Human Insulin Inhalation Powder
- **DRUG:** intensive diabetes management starting with an adjusted dose of Human Insulin Inhalation Powder

## Key facts

- **NCT ID:** NCT00391209
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2018-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391209, "Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00391209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*